(FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | (Q3)Mar 31, 2022 | (FY)Dec 31, 2021 | (Q9)Sep 30, 2021 | |
---|---|---|---|---|---|---|---|---|---|---|
Turnover | 6.95%633.87B | 17.70%467.32B | 15.65%334.46B | 22.39%144.45B | 18.40%592.67B | 13.61%397.04B | 15.22%289.2B | 25.00%118.03B | 25.11%500.57B | 30.42%349.49B |
Operating income | 6.95%633.87B | 17.70%467.32B | 15.65%334.46B | 22.39%144.45B | 18.40%592.67B | 13.61%397.04B | 15.22%289.2B | 25.00%118.03B | 25.11%500.57B | 30.42%349.49B |
Operating expenses | -6.90%-572.46B | -18.21%-424.22B | -15.74%-303.47B | -23.84%-130.81B | -19.69%-535.52B | -14.04%-358.87B | -15.73%-262.19B | -26.32%-105.63B | -26.15%-447.44B | -31.66%-314.68B |
Gross profit | 7.46%61.41B | 12.92%43.11B | 14.72%30.99B | 10.05%13.64B | 7.56%57.15B | 9.66%38.18B | 10.49%27.01B | 14.78%12.4B | 16.97%53.14B | 20.18%34.81B |
Selling expenses | -9.93%-3.17B | -14.71%-2.01B | -13.42%-1.39B | -10.80%-657.85M | -5.12%-2.88B | -0.16%-1.76B | -6.19%-1.23B | -8.42%-593.74M | -12.35%-2.74B | -17.52%-1.75B |
Administrative expenses | -9.64%-12.36B | -10.94%-8.08B | -9.83%-5.43B | -10.56%-3.07B | -3.22%-11.27B | -0.40%-7.29B | 2.02%-4.94B | -1.64%-2.78B | 0.81%-10.92B | -19.98%-7.26B |
Research and development expenses | -5.33%-19.73B | -15.76%-13.54B | -18.99%-9.09B | -7.14%-2.81B | -17.81%-18.73B | -17.88%-11.69B | -27.13%-7.64B | -54.55%-2.63B | -29.00%-15.9B | -35.36%-9.92B |
Profit from asset sales | 118.58%663.08M | -77.69%51.26M | -67.28%33.96M | 117.27%15.84M | -55.99%303.36M | -47.48%229.74M | -75.74%103.78M | -10.24%7.29M | 195.93%689.23M | 2,906.47%437.44M |
Revaluation surplus | 1.12%-314.22M | -10.35%-458.64M | -151.26%-328.38M | -140.28%-3.25M | -278.59%-317.78M | -604.71%-415.61M | -353.88%-130.7M | -25.85%8.07M | 426.07%177.93M | 61.66%82.35M |
-Changes in the fair value of other assets | 1.12%-314.22M | -10.35%-458.64M | -151.26%-328.38M | -140.28%-3.25M | -278.59%-317.78M | -604.71%-415.61M | -353.88%-130.7M | -25.85%8.07M | 426.07%177.93M | 61.66%82.35M |
Impairment and provision | -80.37%-8.95B | -0.78%-4.01B | -5.58%-3.08B | -7.47%-911.58M | 7.07%-4.96B | -25.11%-3.98B | -38.32%-2.92B | -22.29%-848.22M | -45.09%-5.34B | 1.14%-3.18B |
-Other impairment is provision | -80.37%-8.95B | -0.78%-4.01B | -5.58%-3.08B | -7.47%-911.58M | 7.07%-4.96B | -25.11%-3.98B | -38.32%-2.92B | -22.29%-848.22M | -45.09%-5.34B | 1.14%-3.18B |
Special items of operating profit | 14.93%-927.25M | 44.19%-512.87M | 19.45%-506.66M | -85.71%-240.12M | 20.17%-1.09B | -673.91%-919.01M | -18.17%-628.99M | -38.01%-129.3M | -98.44%-1.37B | 62.65%-118.75M |
Operating profit | -9.93%14.7B | 21.42%13.17B | 17.01%10.2B | 8.29%5.49B | 7.28%16.33B | -7.00%10.85B | -2.56%8.72B | 15.90%5.07B | 12.06%15.22B | 25.05%11.67B |
Financing cost | -5.13%-989.12M | -1,280.18%-516.54M | -127.33%-248.6M | 36.71%-192.05M | 10.83%-940.84M | 103.55%43.77M | 89.69%-109.36M | 24.84%-303.44M | 40.30%-1.06B | 32.53%-1.23B |
Special items of earning before tax | 576.18%48.94M | 24.10%29.08M | -249.57%-56.18M | 24.14%29.6M | 104.81%7.24M | -85.00%23.44M | -73.48%37.56M | -70.63%23.84M | -244.21%-150.34M | -36.56%156.19M |
Earning before tax | -10.57%13.76B | 16.21%12.69B | 14.46%9.9B | 11.22%5.33B | 9.85%15.39B | 3.09%10.92B | 7.69%8.65B | 18.22%4.79B | 17.58%14.01B | 36.67%10.59B |
Tax | 4.14%-2.36B | -10.81%-2.19B | 5.60%-1.22B | 5.76%-941.91M | -2.31%-2.46B | 4.18%-1.97B | 10.28%-1.29B | 1.63%-999.49M | 5.13%-2.4B | -11.13%-2.06B |
After-tax profit from continuing operations | -11.80%11.41B | 17.40%10.5B | 17.98%8.68B | 15.69%4.39B | 11.41%12.93B | 4.85%8.94B | 11.62%7.36B | 24.87%3.79B | 23.71%11.61B | 44.70%8.53B |
Earning after tax | -11.80%11.41B | 17.40%10.5B | 17.98%8.68B | 15.69%4.39B | 11.41%12.93B | 4.85%8.94B | 11.62%7.36B | 24.87%3.79B | 23.71%11.61B | 44.70%8.53B |
Minority profit | 3.02%2.74B | 3.74%2.32B | -1.50%1.46B | -8.58%1.02B | -17.84%2.66B | -7.07%2.23B | -10.27%1.48B | 23.46%1.11B | 112.62%3.23B | 86.54%2.4B |
Profit attributable to shareholders | -15.63%8.67B | 21.94%8.18B | 22.90%7.22B | 25.77%3.37B | 22.70%10.28B | 9.52%6.71B | 18.95%5.87B | 25.46%2.68B | 6.52%8.37B | 33.01%6.13B |
Basic earnings per share | -26.67%0.33 | 10.71%0.31 | 8.33%0.26 | 25.00%0.15 | 28.57%0.45 | 7.69%0.28 | 14.29%0.24 | 20.00%0.12 | 9.37%0.35 | 36.84%0.26 |
Diluted earnings per share | -26.67%0.33 | 10.71%0.31 | 8.33%0.26 | 25.00%0.15 | 28.57%0.45 | 7.69%0.28 | 14.29%0.24 | 0.12 | 0.35 | 0.26 |
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
Audit Opinions | Unqualified Opinion | -- | -- | -- | Unqualified Opinion | -- | -- | -- | Unqualified Opinion | -- |
Auditor | Ernst & Young (Special General Partnership) | -- | -- | -- | Ernst & Young (Special General Partnership) | -- | -- | -- | Daishin Certified Public Accountants (Special General Partnership) | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
No Data
No Data